Octreotide(Midatech Pharma)
奥曲肽 （Midatech Pharma）
Report date: 2022/12/29 11:27:20
Base Information
Drug NameOctreotide(Midatech Pharma)
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory
CombinationsNo
Global Highest StatusDiscontinued (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesBiodexa Pharmaceuticals PLC
China Registration ClassN/A
Develop Information
Active CompaniesN/A
Inactive CompaniesBiodexa Pharmaceuticals PLC
Active IndicationsN/A
Inactive Indications
Other Information
ATC CodeN/A
Related LinksN/A